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Background: A-Kinase Anchoring Proteins (AKAPs) are molecular scaffolding proteins mediating the assembly of
multi-protein complexes containing cAMP-dependent protein kinase A (PKA), directing the kinase in discrete
subcellular locations. Splice variants from the AKAP7 gene (AKAP15/18) are vital components of neuronal and
cardiac phosphatase complexes, ion channels, cardiac Ca2+ handling and renal water transport.
Results: Shown in evolutionary analyses, the formation of the AKAP7-RI/RII binding domain (required for AKAP/
PKA-R interaction) corresponds to vertebrate-specific gene duplication events in the PKA-RI/RII subunits. Species
analyses of AKAP7 splice variants shows the ancestral AKAP7 splice variant is AKAP7α, while the ancestral long form
AKAP7 splice variant is AKAP7γ. Multi-species AKAP7 gene alignments, show the recent formation of AKAP7δ occurs
with the loss of native AKAP7γ in rats and basal primates. AKAP7 gene alignments and two dimensional Western
analyses indicate that AKAP7γ is produced from an internal translation-start site that is present in the AKAP7δ cDNA
of mice and humans but absent in rats. Immunofluorescence analysis of AKAP7 protein localization in both rat and
mouse heart suggests AKAP7γ replaces AKAP7δ at the cardiac sarcoplasmic reticulum in species other than rat.
DNA sequencing identified Human AKAP7δ insertion-deletions (indels) that promote the production of AKAP7γ
instead of AKAP7δ.
Conclusions: This AKAP7 molecular evolution study shows that these vital scaffolding proteins developed in
ancestral vertebrates and that independent mutations in the AKAP7 genes of rodents and early primates has
resulted in the recent formation of AKAP7δ, a splice variant of likely lesser importance in humans than
currently described.
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AKAP15/18Background
cAMP-dependent protein kinase A (PKA) is a broad-
specificity serine/threonine protein kinase that is ubiqui-
tously distributed among tissue types, and identified in
organisms from fungi to humans. Inside cells, PKA
exists as a tetrameric protein composed of two catalytic
subunits and a regulatory subunit dimer. The PKA regu-
latory subunit (PKA-R) functions to maintain kinase
inactivity in the absence of cAMP and form protein-
protein interactions that compartmentalize the kinase.* Correspondence: rdanziger@aol.com
1Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
4Jesse Brown VA Medical Center, Chicago, IL, USA
Full list of author information is available at the end of the article
© 2012 Johnson et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orThe selective sequestration or compartmentalization of
intracellular PKA has been supported by several studies
showing that PKA is concentrated in discrete intracellu-
lar locales by A-kinase anchoring proteins, or AKAPs
[1-4]. AKAPs bind to the regulatory (i.e., PKA-RI, PKA-
RII or both) subunit dimer of the tetrameric PKA holo-
enzyme at an antiparallel four-helix domain termed
the dimerization and docking (D/D) domain [5-7]. The
AKAP-PKA-R interaction functions to sequester PKA in
the vicinity of its phosphorylation substrates [2,8,9] and
this selective concentration of PKA activity in part,
explains how multiple diverse extracellular stimuli can
result in highly specific and discrete PKA-mediated
phosphorylation events [10,11].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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weight, AKAPs are now designated by gene number (i.e.,
AKAP15/18 splice variants are referred to as AKAP7 splice
variants). Currently there are 14 annotated AKAPs
(AKAP1 to AKAP14). The PKA-regulatory subunit bind-
ing domain of AKAPs is the most recognizable element
among the otherwise structurally diverse protein family.
AKAPs are classified according to binding specificity for
the PKA regulatory subunits; RI-, RII- or both RI and RII
PKA regulatory domains (dual specific) [12]. The primary
structure (i.e., amino acid sequence) of the PKARI/RII-
binding domain is highly variable among AKAPs, though
the secondary structure, which forms an amphipathic helix,
contains several conserved hydrophobic residues that de-
termine PKA-R-subunit specificity and binding affinity
[13-15]. AKAPs also contain unique localization signal(s)
which are responsible for AKAP targeting to sub-cellular
compartments, and in many cases, AKAPs also contain
enzyme-binding sites that enable the formation of multi-
protein signaling complexes [16,17]. Various AKAP target-
ing domains have been shown to interact with G-protein
coupled receptors (GPCRs; [18]), adenylyl cyclases [19],
Exchange protein activated by cAMP (EPAC; [20]), and
phosphodiesterases (PDEs) [21,22]. Hence, AKAPs func-
tion as signal processing hubs specifically linking upstream
activation signals to downstream effector proteins.
AKAPs have been shown to regulate neuronal ion
channels [23,24], memory and cognition [25-27],
reproduction function [22,28], as well as renal [29] and
cardiac function [11,30-35]. One AKAP that has been
identified in many tissues and a variety of cell signaling
pathways is AKAP7 (also known as AKAP15/18). Splice
variants of the AKAP7 gene (AKAP7α, β, δ, and γ) are
dual-specificity AKAPs that have been extensively stud-
ied in central nervous system (CNS), striated muscle ion
channel regulation [2,36,37], cardiac calcium cycling
[38], and renal aquaporin transport [29].
AKAP7α, the first AKAP7 splice variant identified, is a
membrane bound protein containing a lipid modification
domain in the amino terminus [39]. AKAP7α binds to L-
type Ca2+ channels where it regulates the PKA-dependent
phosphorylation of the ion channel [40]. AKAP7α has also
been shown to interact with sodium channels in the brain
[2], and is required for feedback inhibition of the epithelial
Na+ channel (ENAC) [41]. AKAP7α-mediated PKA
anchoring to ion channels (Ca2+ and Na+) provides a regu-
latory mechanism for channel function, whereby anchoring
of PKA regulates the phosphorylation state of the ion
channel and has a profound effect on channel “open prob-
ability” and ion movement [1,40,42,43]. Another exten-
sively studied AKAP7 splice variant is AKAP7δ, which was
originally identified in rat kidney [29]. In rat renal principle
cells, the APAK7δ splice variant functions to anchor PKA
to intracellular vesicles containing the aquaporin waterchannel and is required for aquaporin fusion to the plasma
membrane [29]. Also in rats, AKAP7δ has been identified
in the cardiac sarcoplasmic-endoplasmic reticulum ATPase
(SERCA) where it regulates PKA phosphorylation of a
SERCA negative regulatory protein, phospholamban (PLN)
and controls Ca2+ re-uptake into the sarcoplasmic
reticulum (SR) [38]. AKAP7δ has become a prime example
for the pharmacological potential of PKA-AKAP disruptor
molecules, particularly in the treatment of human heart
failure [44,45]. Much less is known about the AKAP7β and
γ splice variants. AKAP7β differs from AKAP7α by the in-
clusion of a third exon which imparts a unique membrane
localization that differs from that found for AKAP7α [46].
AKAP7γ has been cloned from human pancreas [46] and
mouse oocytes [47], though the functional significance of
this splice variant remains relatively unknown.
Though appreciation for the importance of AKAPs in
cell signaling has grown exponentially in recent years, an
analysis of the evolution and development of an AKAP
remains absent. This study addresses several key ques-
tions in the molecular evolution of AKAP7 proteins
including; 1) evolution/genesis of the AKAP7 RI/RII
binding domain in relation to the PKA-R D/D domains
2) evolution of the AKAP7 gene structure 3) species
analyses of AKAP7 splice variants, 4) sequence deter-
mination of previously un-reported mouse and human
AKAP7δ and 5) evolutionary conservation of key protein
regions in short AKAP7 splice variants and rapid change
in AKAP7 long form splice variants.
Results
Evolution of AKAP7 and PKA-R interaction motifs
The AKAP7 protein domain required for PKA-R binding
(AKAP7 RI/RII binding domain; pfam 10470) is detected
in transcripts of species from zebrafish to humans
(Figure 1). The 3’ terminal exon encoding the AKAP7
RI/RII binding domain first appears in the AKAP7 gene of
lamprey and is conserved throughout vertebrates, placing
AKAP7 binding domain genesis at the base of the verte-
brate lineage (Figures 2 and 3). Transcripts containing
(encoding) the AKAP7RI/RII binding domain were not
identified in Drosophila and Ciona, though transcripts
containing high sequence identity to the AKAP-7 NLS
were identified (termed AKAP7-like; Figure 1). AKAP7-
like genes were also identified in Strongylocentrotus pur-
puratus (Additional file 1: Figure S1), Chlorella variabilis,
and Daphnia pulex (not shown). The resultant putative
protein products of these AKAP7-like genes lack the
AKAP7RI/ RII binding domain and likely the PKA bind-
ing functionality of derived AKAPs.
The PKA-R subunit protein domain necessary for
AKAP interaction (the Dimerization/Docking, D/D do-
main; pfam 02197) is conserved in the PKA-R subunits
of insects, urochordates, chordates, and vertebrates (with
AKAP7-NLS AKAP7-RIRII bdg
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Figure 1 Co-Evolution of PKA-R and AKAP7 RI/RII binding domains. A phylogenetic tree was constructed using PKA-R amino acid
sequences. Bootstrap values are indicated next to each branch. PKA-R gene duplication events are indicated by *. PKA-R and AKAP7 protein
families identified in species composing each clade are shown adjacent to the PKA-R phylogenetic tree. The PKA-R dimerization/docking (D/D)
domain is identified in invertebrate and vertebrate species, while the AKAP7 RI/RII binding domain appears in vertebrate species following PKA-R
gene duplication events. The PKA-RIIβ subunit in zebrafish lacks the AKAP7 RI/RII binding domain.
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Specifically, the residues necessary for PKA-R/AKAP7
interaction [5,7,13,15] are conserved in all species exam-
ined (Figure 2). Appearance of the AKAP7 RI/RII bind-
ing domain corresponds with the vertebrate specific
PKA-R gene duplication (Figure 2).
AKAP7 Splice variant evolution
AKAP7 gene structure, exon numbers and orientation
were determined for multiple species (Figure 3, Add-
itional file 1: Figure S1). AKAP7α coding sequence in
the AKAP7 gene and EST transcript evidence firstappears in basal teleosts (Danio rerio), and is conserved
from teleosts to humans (Figure 3, Additional file 1:
Figure S1). AKAP7β ESTs are only identified in mam-
mals (pig; Sus scrofa; Additional file 1: Figure S1),
though the AKAP7β-specific gene coding region is detect-
able from marsupials to mammals (Figure 3). AKAP7δ is
the most recent AKAP7 splice variant, with EST evidence
supporting transcript presence in rats through humans.
However exon data suggests this splice variant is absent
from AKAP7 genes in species below laurasiatherian mam-
mals (Additional file 1: Figure S1, Figure 4). AKAP7δ is







Hsap     ELVRLSKRLVENAVLKAVQQY
Rnor     ELVRLSKRLVENAVLKAVQQY
Mdom     ELVRLSKKLVENAVLKAVQQY
Xtro     ELLSLSKRLVENAVLKAVQQY
Drer     ELLSLSKRLVEDAVLRAMQQY
Pmar     ELAALSRRLVDTAVKRAVLQL
AKAP7 RI/RII Binding Domain
* * **
A
Hsap   KHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAK
Mmus   KHNIQALLKDSIVQLCTTRPERPMAFLREYFERLEKEEAR
Btau   KHNIQALLKDSIVQLCTARPERPMAFLREYFEKLEKEEAK
Ggal   KHNIQQLLKDCIVQLCTVRPDRPMGFLREYFERLEKEETK
Xtro   KHNIQQLLKDCIVQLCTVRPACPMAFLREYFERLEKEEAR
Drer   KHNIQQLLKDCIVQLCTARPERPMAYLRDYFEKLELEEAK
Pmar   RHGIQAVLKQCIVQLCIARPERPMQFLREHFERLEKEEAK





C PKA-RI D/D Domainβ
Hsap   YVQLHGIQQVLKDCIVHLCISKPERPMKFLREHFEKLEKEEN
Mmus   YVQKHGIQQVLKECIVHLCVAKPDRPLRFLREHFEKLEKEEN
Btau   YVQRRGIQQVLKDCIVQLCLAKPERPMRFLREHFERLEKEEN
Ggal   YVQKHNIQQILKECIVNLCIAKPDRPMKFLREHFEKLEKEEC
Xtro   YVQKYNIQQLLKECIVNLCIAKPDRPMKFLREHFEKLEKEEC
Drer   FVQKHNIQQILKECIVNLCIAKPERPMKFLREHFEKLEKEEC
Pmar   YVQKHNIQALLKDCIVQLCVARPERPMRFLREFFEKLEKEQL
Cint   YVHEHKIQQTLKDCIVQLCIHKPEKPMKFLREHFEALEKEEA
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Figure 2 Amino Acid Alignments of AKAP7 RI/RII binding domain and PKA-R D/D domains. Protein regions from the AKAP7 RI/RII binding
domain (A), PKA-RIIα dimerization/Docking domain (D/D; B), PKA-RIα D/D (C) PKA-RIβ D/D, (D), and PKA-RIIβ (E) were aligned using Clustal X. (A)
Residues in the AKAP7 RI/RII binding domain that have been previously identified as components of an amphipathic α-helix necessary for PKA-R
subunit interaction are indicated by (*) and residues that are conserved are shaded. In the AKAP7 RI/RII binding domain, α-helix forming residues
are conserved in vertebrates from lamprey to humans. Residues in the PKA-RIIα (B), PKA-RIα (C), PKA-RIβ (D), and PKA-RIIβ (E) D/D domains
forming the docking surface for the AKAP helix which are highly conserved are indicated by shading. Residues in PKA-RIIα that are essential for
AKAP binding [48,49] are indicated by (*). The spacer region between helices in PKA-RIIα is indicated by a dotted line.
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AKAP7γ 5’ exon from cow to human (Figure 4). The
appearance (expression) of the AKAP7δ splice variant
coincides with the loss of expression for AKAP7γ in
both rat and marmoset (Calithrix jacchus) EST data-
bases, as well as the integration of a smaller AKAP7γ 5’
exon in the mouse transcript which results in a trun-
cated AKAP7γ amino terminus unique to mouse
(Figure 4).
The sequencing of human and mouse AKAP7δ and
alignment with rat AKAP7δ validates the presence of
the multiple nucleotide mutations resulting in the trun-
cation of AKAP7γ in mice and loss of AKAP7γ in rats
(Additional file 2: Figure S2). Mouse AKAP7δ has a 79%
nucleotide sequence identity compared to human
AKAP7δ (74 % amino acid identity), and rat AKAP7δ
has 78% nucleotide sequence identity to human
AKAP7δ. Both rat and mouse AKAP7δ splice variants
contain an “RGD” amino acid sequence that is absent in
human AKAP7δ (Additional file 2: Figure S2).
Replacement of AKAP7γ with AKAP7δ indicates similar
function
Multiple sequence nucleotide alignments identified
mutations in the AKAP7 genes of rat, mouse, and mar-
moset which result in the loss of (in rat and marmoset)
or truncation of (in mouse) the AKAP7γ splice variant
and incorporation of the AKAP7δ splice variant(Figure 4). In the rat AKAP7 gene, the putative AKAP7γ
initiation codon contains two nucleotide mutations
where “ATG” in the Kozak sequence is mutated to
“GGG”, the result of a transition at position 1 of the
codon (A!G), and a transversion at position 2 of the
codon (T!G) yielding the missense mutation Met!
Gly. In the mouse AKAP7 gene, a cognate mutation was
also identified in the putative AKAP7γ initiation codon
as a single transition at nucleotide position 1 (A!G)
replaces the AKAP7γ start codon with “GTG”, resulting
in the missense mutation Met!Val. Also identified in
the mouse AKAP7 gene, a second mutation downstream
of the AKAP7γ initiation codon results in the formation
of an internal start site where an “ATG” is formed as the
result of a nucleotide transversion (C!A), yielding the
amino acid Leu!Met mutation which yields a trun-
cated AKAP7γ splice variant in mouse (Figure 4). The
AKAP7γ mutations in the rodent lineage seem to be
specific to rats and mice, as another rodent (Oryctolagus
cuniculus; rabbit) lacks these mutations, and also
altogether lacks the AKAP7δ 5’ exon (Figures 3 and 4).
The loss of AKAP7γ is also evident in marmoset, as
“ATG” is replaced by “ATA”, the result of a transition at
position 3 of the initiation codon (G!A) replacing Met
with Ile.
Two-dimensional western analysis of recombinant rat
and mouse AKAP7 long-form splice variants confirms




























Figure 3 AKAP7 Gene Evolution. AKAP7 ESTs from chordate (Ciona Intestinalis), basal vertebrate (lamprey), teleost (zebrafish), and mammals
(Opossum, Dog, Rat, and Human) were aligned to their respective genomes to determine exon positions and orientation. Coding sequence for
the AKAP7 RI/RII binding domain is found in the 3’ terminal exon of AKAP7 splice variants and is identified in the AKAP7 genes from lamprey to
humans. The AKAP7α 5’ exon first appears in zebrafish and an ortholog of this exon is identified in the genes of multiple mammals. The
AKAP7β-specific exon first appears in the dog AKAP7 gene and is conserved in mammalian genes. An AKAP7 long form splice variant is found in
each species, though AKAP7γ orthologs are only identified in species following the divergence of dog. The AKAP7γ 5’ exon is lost in rats, and is
concomitant with the incorporation of the AKAP7δ 5’ exon (AKAP7δ exon is identified in the cow AKAP7 gene but no ESTs were detected).
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cDNA from mice (Figure 5). It is also apparent that
mouse AKAP7γ is the major product from AKAP7δ
cDNA (Figure 5A), which is likely the result of an
AKAP7γ internal translational start site that is present
in mice, but absent in rats (Figure 4). AKAP7 immuno-
precipitations (IPs) identified AKAP7δ and a variant of
AKAP7δ (see below) in rat heart, while AKAP7δ,
AKAP7γ, and unknown variants were seen from mouse
heart IPs (Figure 5). Comparison of rat and mouse
AKAP7 cardiac localization by immunofluorescence
(Figure 6) shows identical localization compared be-
tween rat (AKAP7δ only) and mouse (predominantly
AKAP7γ but also AKAP7δ). The pattern of AKAP7 car-
diac immunstaining in rat and mouse is consistent with
localization to the sarcoplasmic reticulum, as previously
reported for AKAP7δ in rat [38].Insertion-deletions in human and Rat AKAP7δ yield novel
splice variants
Sequencing of human AKAP7δ identified splice variants
containing nucleotide sequence insertions and deletions
(indels). Human AKAP7δ variant-1, contains a seventy
five nucleotide insertion between the first and second
exons of AKAP7δ (located 5’ to the AKAP7γ start
codon; Figure 7), and an exon deletion (AKAP7δ exon 6;
Figure 7). AKAP7δ variant-2 contains two insertions; a
sixty nine-nucleotide insertion between AKAP7δ exons
1 and 2, and a sixty nine nucleotide insertion between
AKAP7δ exons 7 and 8 (Figure 7). The upstream inser-
tion sequence in AKAP7δ variant-1 has 100 % sequence
identity to a region in the human AKAP7 gene (located
on chromosome 6) between the AKAP7δ 5’ exon and
AKAP7δ exon 2. The upstream insertion sequence in
















G  G  I  N  S  N  E  C  E  N  V  S  R  K  K  K
...GTTAAAGGAGGAATTAATTCCAATGAGTGTGAAAATGTATCAAGAAAAAAGAAAATGTTAGAGGAATTTGAAGCCAATACTATGGATTCTCTGATAGACATGCCATTTGCCACT...
G  G  I  N  S  N  E  C  E  N  V  S  R  K  K  K
...GTTAAAGGAGAAATTAATTCCAATGAGTGTGAAAATGAATCAAGAAAAAAGAAAATGTCGGAGGAATTTGAAGCCAATACTATGGATTCTCTGGTAGACATGCCATTTGCTACT...
G  E  I  N  S  N  E  C  E  N  E  S  R  K  K  K
...GTTAAAGGAGGAATTAATTCCAATGAGTGTGAAAATGTATCAAGAAAAAAGAAA   TCAGAGGAATTTGAAGCCAGTACTATGGATTTCCTGGTAGAC   CCATTTGCTACT...
...GTTGCAGGAAAACTAGATTCCGGTACGTGTGAACATATATCAGGAGAAGAGGAA   GCACGAGAACTGGAACCCAGCCCTGTAGGTTCCCTGACAGAC   CCGTTTGCTGCT
G  K  L  D  S  G  T  C  E  H  I  S  G  E  E  E  V  A  R  E  L  E  P  S  P  V  G  S  L  T  D































































Figure 4 Multi-species AKAP7 gene alignments. (A) AKAP7 gene sequence and coding regions of AKAP7 long form splice variants δ and γ
from several mammals were aligned using Clustal. Translated protein sequence has been added for splice variants with EST or sequencing
support from this study. Position of the AKAP7δ 5’ exon and flanking intron are indicated with solid lines and arrows, the 5’ and 3’ splice
junctions are denoted with (҂). The AKAP7δ 5’ exon is only present in the AKAP7 genes of cow, rat, mouse, and primates. The putative AKAP7γ
start codon is indicated with (*), the methionine (M) at this position has mutated to a glycine (G) in rats, valine (V) in mice, and isoleucine (I) in
marmoset. AKAP7γ is initiated at a downstream methionine in mice, indicated by (#). This codon is mutated to a leucine (L) in rats. Species where
AKAP7δ is the only AKAP7 long form splice variant produced are indicated by (**). (B) A protein model was constructed to represent the AKAP7
long form splice variant complement for species shown in (A). The ancestral AKAP7γ splice variant is present in cow and human, absent in rat,
and truncated in mouse.
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http://www.biomedcentral.com/1471-2148/12/125AKAP7 gene. The downstream insertion sequence in
AKAP7δ variant-2 has 100% sequence identity to the
AKAP7β-specific sequence. PCR amplification of the
human AKAP7δ indel regions show the 5’ insertion is
predominant relative to the native form, while the
deletion-variant is less prominent than the native tran-
script form (Figure 7C). The AKAP7δ splice variant con-
taining the AKAP7β exon is a minor product but is
identified in most tissues (Figure 7C).Open reading frame (ORF) analysis of Human
AKAP7δ transcript variants-1 and 2 (Figure 8) show that
the AKAP7δ 5’ insertions shifts the reading frame down-
stream to begin initiation at the AKAP7γ coding region
(Figure 8A), while the downstream exon deletion seen in
AKAP7δ variant-1 results in a truncated protein that
contains the AKAP7 nuclear localization signal (NLS),
but lacks the AKAP7 RI/RII binding domain (Figure 8B).
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Figure 5 2D Western Analysis of AKAP7δ and AKAP7γ. Recombinant mouse AKAP7δ, AKAP7γ, and rat AKAP7δ were analyzed by two-
dimensional western blotting. V5-tagged Mouse AKAP7δ (A), AKAP7γ (B) or rat AKAP7δ (C) were detected from transfected HEK293 cell lysates
using a V5-HRP antibody. (D) Mock-transfected HEK293 cell lysates were probed with V5-HRP as a negative control. (E) Rat heart lysate used in
AKAP7 immunoprecipitations (using AKAP7 antibody) was probed with protein A-HRP. Two products are identified, rat AKAP7δ, and a variant of
rat AKAP7δ identified in this study (rat AKAP7δ variant 1, see Supplemental Information Figure 3). (F) Mouse heart lysate subjected to AKAP7
immunoprecipitation followed by detection with protein A-HRP. Mouse AKAP7δ and AKAP7γ are identified in addition to two unknown splice
variants (indicated by red arrows). For negative control immunoprecipitations rat heart lysate (G) or mouse heart lysate (H) was
immunoprecipitated with rabbit IgG (pre-immune serum) followed by detection by protein A-HRP. The pH range and molecular weight are
indicated at the top and left (respectively) of each blot.
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containing the AKAP7 NLS, AKAP7 RI/RII binding do-
main and the AKAP7β protein region (Figure 8C).
Two exon-deletion transcript variants were also identi-
fied in rat AKAP7δ (Additional file 3: Figure S3).
AKAP7δ variant-1 contains deletions at exons 3–6,
while variant-2 contains a deletion of exon 6. Of these
variants, only rat AKAP7δ variant-2 contains the AKAP7
RI/RII binding domain. No indels were detected from
sequencing mouse AKAP7δ, however a short (3-exon)
AKAP7γ splice variant was detected in mouse ESTs(Acc# BC099487.1), and is marginally expressed in
mouse spleen (Additional file 4: Figure S4).
Conservation in AKAP7 short splice variants
AKAP7 short splice variants (AKAP7α and β) have pro-
nounced sequence conservation across the vertebrate
phyla. Nucleotide sequence alignments of the AKAP7 α/
β 5’ exon show that this exon is highly conserved from
zebrafish to humans (Additional file 5: Figure S5), as the
nucleotide sequence homology for this exon ranges from
66 to 98 % identity. Amino acid alignment of the
Figure 6 AKAP7 Localization in rat and mouse heart. Merged immunofluorescence images of (A) adult rat and (B) mouse hearts were taken
using a confocal microscope. Immunostaining was performed using a rabbit anti-AKAP7 antibody, the 2˚ Ab is Alexa fluor 488 anti-rabbit. Nuclei
are stained with Dapi (blue). AKAP7 immunostaining is prominent in the sarcoplasmic reticulum in both rat (expressing AKAP7δ only) and mouse
(predominantly AKAP7γ but also AKAP7δ). In the negative controls for rat (C) and mouse (D) normal rabbit serum (AKAP7 pre-immune serum)
was used in place of the AKAP7 primary antibody. Images were taken at 60X magnification.
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http://www.biomedcentral.com/1471-2148/12/125AKAP7α/β amino terminus (Additional file 3: Figure S3)
shows this protein region has a sequence homology of
70 to 100% from zebrafish to humans.
AKAP7β is distinguished from AKAP7α by the inclu-
sion of a 69-nucleotide exon between the AKAP7 α/β 5’
exon and the AKAP7 3’ terminal exon. This AKAP7β-
specific exon is found in the genomes of several mam-
mals (Figure 3, Additional file 1: Figure S1), and is highly
conserved (Additional file 5: Figure S5). Amino acid
alignment of the AKAP7β-specific protein region shows
sequence homology of 65 to 95% from pigs to human
(Additional file 5: Figure S5).
Tissue Expression of AKAP7 splice variants in rodents
and humans
AKAP7δ is ubiquitously expressed in human, mouse and
rat tissues (Figure 9). AKAP7α expression is expressed
in several rodent and human tissues, with conserved ex-
pression seen between rat, mouse and human heart, kid-
ney, brain, liver and lung (Figure 9). AKAP7β mRNA
expression is also detected in multiple tissues in rodent
and human, though conserved expression betweenrodents and humans is only seen in the kidney, with the
predominant AKAP7β expression site is the pancreas in
humans (Figure 9).
Discussion
In this study we have provided the first evolutionary
analysis of an AKAP. The significance of PKA signaling
has been shown throughout eukaryotic organisms. Here,
we show the AKAP7 RI/RII binding domain appears in
basal vertebrates, corresponding to a PKA-R subunit
gene duplication event. In the molecular evolution of
the AKAP7 gene, AKAP7 short splice variants appeared
early in the vertebrate lineage and have remained highly
conserved. In the AKAP7 long form splice variants, mul-
tiple nucleotide mutations and insertions-deletions have
resulted in the concurrent loss of AKAP7γ and forma-
tion of AKAP7δ in rats. Specifically in rats, the replace-
ment of AKAP7γ with AKAP7δ, as shown in this study,
has likely lead to an over-statement of the significance of
AKAP7δ in species other than rat [29,38,44,50,51]. Evo-
lutionary pressures in the form of nucleotide insertions
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Figure 7 Insertion-Deletion Variants of Human AKAP7δ. (A) PCR amplification of human AKAP7δ shows two splice variants of different length
following agarose gel electrophoresis. (B) In AKAP7δ variant-1 an insert sequence is found between AKAP7δ exons-1 and 2 and AKAP7δ exon-6 is
deleted. An insert sequence between exons-6 and 7 is identified in AKAP7δ variant-2 in addition to the 5’ insert sequence. (C) PCR amplification
was used to determine the expression of AKAP7δ variants-1 and 2 in human tissues (relative docking sites for primer pairs are shown in 7B). In
PCR set I, the 5’ insert sequence is predominantly present in all tissues relative to the non-insert product (native). In PCR set II, the native form is
the major product relative to the AKAP7δ exon-6 deletion found in variant-1. Shown in PCR set III, the 3’ insert sequence found in variant-2 is a
minor product in the liver and pancreas relative to the native form.
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in humans. Hence, it is likely that AKAP7δ is of
minimal significance in human AKAP7-mediated PKA
signaling.
Integration of the AKAP7-RI/RII binding domain and PKA-
R Dimerization/Docking domain in vertebrate evolution
While AKAP7-like proteins were identified in inverte-
brate and chordate species, the appearance of the RI/RII
binding domain (and formation of AKAP7 proteins)
occurs in basal vertebrates (lamprey). The formation of
AKAP7 proteins from AKAP7-like proteins corresponds
with PKA-R gene duplication events where the PKA-RI
gene duplicates to form PKA-RIα and PKA-RIβ, and
PKA-RII forms PKA-RIIα and PKA-RIIβ. Evolution of
the PKA-R subunits has been previously described [52].
Here we provide greater resolution of the timing of
PKA-R gene duplications, and show that the amino acid
sequences of PKA-R D/D domains are highly conserved,
even prior to the gene duplication events. The relative
fixation of PKA-R D/D sequences prior to and following
the appearance of the AKAP7 RI/RII binding domain
suggests that AKAP7 evolved subsequent to the
increased presence of PKA (the result of PKA-R geneduplications). This is supported by the relatively rapid
development of the AKAP7 RI/RII binding domain
which is absent in chordates (ciona), but present in ver-
tebrates (lamprey).
Origin of AKAP7δ, the need for an AKAP7 long-form
splice variant
As seen in our AKAP7 gene and splice variant phylogen-
etic analyses, AKAP7γ is the ancestral AKAP7 long form
splice variant in mammals. Several nucleotide mutations
identified in the murine lineage (as well as a basal pri-
mate) resulted in the loss of AKAP7γ through mis-sense
mutations in the translational start codon. The most
dramatic of these mutations occurs in rats, where the
AKAP7γ initiation codon contains a successive transition
and rare transversion that results in glycine replacing me-
thionine. The results of these mutations have been con-
firmed in NCBI database searches, as rat AKAP7γ has
been removed from the database (acc. #XM_001053676.1
has been removed), mouse AKAP7γ is truncated (acc.
#NM_018747.4) and marmoset EST search results show
AKAP7γ is not present whereas AKAP7δ is expressed
(accession number XM_002746958.1). The combination
of the AKAP7γ initiation codon loss combined with the
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Figure 8 Open Reading Frame Analysis of Human AKAP7δ insertion-deletion variants. Human AKAP7δ splice variants were assessed for
open reading frames using the NCBI ORF finder. (A-C) Coding and protein sequence for the AKAP7δ amino terminus is indicated by a dotted
box, reading frame initiation is indicated by an arrow, and the AKAP7 NLS has a dotted underline. The AKAP7 RI/RII binding domain (if present) is
identified in a solid box and termination codons are indicated by an (*). (A) The 5’ insertion identified in the majority of human tissues contains
two termination codons and results in a reading frame shift yielding the AKAP7γ splice variant. (B) The 5’ insertion combined with deletion of
exon-6 results in a truncated protein with the AKAP7γ amino terminus. (C) The 5’ insertion combined with the insertion of the AKAP7β exon
yields a protein with the AKAP7γ amino terminus, the AKAP7 NLS, the protein region previously identified only in AKAP7β, and the AKAP7 RI/RII
binding domain.
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http://www.biomedcentral.com/1471-2148/12/125concurrent absence of a downstream initiation codon
utilized in mice (and present in the AKAP7 genes of
several other species), likely yielded the evolutionary
pressure for the incorporation of the AKAP7δ 5’ exon
in rats.In vitro analyses of mouse AKAP7γ, AKAP7δ and rat
AKAP7δ show that both γ and δ splice variants are pro-
duced from the mouse AKAP7δ transcript, suggesting
that AKAPγ is an internal translational start site product
of AKAP7δ production. This is consistent with our
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Figure 9 Tissue Expression of AKAP7 Splice Variants. PCR amplification and agarose gel electrophoresis of AKAP7δ, α and β splice variants
from (A) human, (B) mouse and (C) rat tissue cDNA. AKAP7α tissue expression is conserved among human, mouse, and rat heart, brain, liver and
lung. AKAP7β tissue expression is conserved in the kidney, and AKAP7δ is ubiquitously expressed in humans, mice and rats.
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http://www.biomedcentral.com/1471-2148/12/125AKAP7 gene analysis and provides a different model for
AKAP7 long form splice variants than have been previ-
ously reported [29,53]. Our results also suggest that
AKAP7γ is the major product of AKAP7δ transcription
and translation. In rats, only a single protein product
was identified from recombinant AKAP7δ expressionwhich is consistent with gene and EST alignments show-
ing the loss of AKAP7γ in rats. Findings from previous
studies that have addressed AKAP7γ synthesis and func-
tion in rats [53,54] should be solely attributed to
AKAP7δ as the AKAP7γ splice variant is absent in rats.
The significant role of AKAP7δ in the renal aquaporin
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http://www.biomedcentral.com/1471-2148/12/125shuttle [29], and regulation of cardiac Ca2+ cycling [38]
has led to a concerted effort to develop AKAP7δ pepti-
domimetics for use in treating human heart failure
[44,50]. Results from this study show that AKAP7δ is
the sole AKAP7 long form splice variant found in rats,
and the significance of this splice variant is very likely
over-stated. Combined with the identification of nucleo-
tide insertions in the 5’ end of human AKAP7δ that
would exclusively promote the production of AKAP7γ
in all tissues, the evidence presented here indicates that
the functional significance of AKAP7δ is minimal in spe-
cies other than rats. In mice, where AKAP7γ appears to
be the dominant product of AKAP7δ transcription and
translation, cardiac AKAP7 immunlocalization is con-
sistent with the SR indicating AKAP7γ largely replaces
AKAP7δ at the SR in species other than rat and sup-
ports the possibility that AKAP7δ and AKAP7γ are
functionally redundant in mice. Further studies are
required to determine the functional consequences and
distinction between AKAP7δ and AKAP7γ in mice and
human skeletal muscle.
Evolutionary pressure for replacing AKAP7δ with AKAP7γ
AKAP7δ has been identified as a vital component in car-
diac Ca2+ handling at the sarcoplasmic reticulum in rats
[38] and has been proposed as a pharmacological target
in treating heart failure [44,50]. Our evolutionary ana-
lysis of the AKAP7 gene has shown that the origin of
AKAP7δ was brought about through a series of nucleo-
tide mutations in the AKAP7γ coding sequence in rats,
hence likely leading to exaggeration of the functional
significance of AKAP7δ. This is supported by in vitro
analysis of mouse AKAP7δ, where AKAP7γ (through a
likely internal translation initiation site) is the major
product. AKAP7 immunoprecipitations from rat and
mouse heart tissue also show AKAP7δ and an AKAP7δ
variant in rat while in mouse heart AKAP7δ is a minor
product and AKAP7γ is prominent. Furthermore, se-
quencing of human AKAP7δ (this study) showed the
dominant presence (in multiple tissues) of a nucleotide
sequence insertion immediately downstream of the
AKAP7δ 5’ codon, resulting in a reading-frame shift that
promotes the production of AKAP7γ. Therefore AKAPγ
is the predominant, functional AKAP7 long form splice
variant in humans and pharmacological efforts in
designing AKAP7δ disruptor peptides should instead be
directed at AKAPγ.
AKAP7 short form splice variant evolution
Found only in the vertebrate lineage, AKAP7α is the an-
cestral AKAP7 splice variant and has conserved tissue
expression in rodents and human heart, kidney, brain,
liver and lung. AKAP7α has been extensively studied in
the heart and brain, where this protein regulates PKAlocalization to (and phosphorylation of ) ion channels
such as the L-type Ca2+ channel [1,40,55,56] and epithe-
lial Na+ channels [2,36,37,41]. Deletion of a specific re-
gion in the cardiac voltage-sensitive Ca2+ channel
abolishes AKAP7 binding leading to cardiac hypertrophy
and premature death in mice, and demonstrates the im-
portance of AKAP7α mediated PKA signaling in adren-
ergic stimulation [57]. As seen in the expression results
in this study, it is also likely that AKAP7α has a con-
served role in ion channel regulation in kidney, liver and
lung. AKAP7α amino-terminal amino acids that have
been previously identified [1] in membrane targeting
through myristolation (glycine at position 2; Figure 9) or
palmitoylation (cysteins at positions 5 and 6; Figure 9)
are absolutely conserved from zebrafish to humans.
Furthermore, hydrophobic residues (leucine-4,
phenylalanines-7 and 9, arginine-11) in the AKAP7α
amino terminus which are likely to be critical for mem-
brane localization are also conserved between zebrafish
and humans. Given the high degree of sequence conser-
vation in the AKAP7α amino terminus, it is likely this
protein functions in membrane ion channel regulation
throughout vertebrate species following the divergence
of lamprey.
Development of the AKAP7β exon occurred in mam-
mals (opossum), and while AKAP7β and α splice variants
share the same amino terminus, the AKAP7β-specific
exon confers a cellular localization distinct from the
AKAP7α splice variant [46]. The functional significance
of the AKAP7β splice variant in mammals remains
unknown, though the sequence conservation in this pro-
tein is certainly suggestive of its importance. AKAP7β is
primarily conserved in the kidney of rodents and human,
and it seems likely that this splice variant has a conserved
function in renal ion channel regulation. Importantly,
in this study we have identified a novel AKAP7 long-
form splice variant containing the β-exon. Further studies
are required to address the unique membrane-localizing
function of this AKAP7 protein region.Conclusions
Our results show that the formation of AKAP7 proteins
occurred in basal vertebrate species, likely in response to
the increased presence and distribution of intracellular
PKA following PKA-R gene duplication events. Short
form splice variants from AKAP7 genes have remained
highly conserved across species, while long forms have
undergone rapid evolutionary change. Independent
mutations in the AKAP7 genes of rats, mice and mar-
moset have resulted in loss or truncation of AKAP7γ
and a likely compensatory incorporation of AKAP7δ.
These results suggest that studies of AKAP7δ are not
necessarily comparable among rats, mice and humans.
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http://www.biomedcentral.com/1471-2148/12/125The specific targeting of human AKAP7δ in pharmaco-
therapeutics should be undertaken with caution, as this
splice variant is largely absent in humans.
Methods
Sequence data acquisition
Human and rodent AKAP7 splice variant sequences
were obtained from NCBI and ENSEMBL (release 61)
databases by searching for the gene “AKAP7” and
AKAP7 transcripts. Annotated AKAP7 proteins were
analyzed for conserved AKAP7 protein families (Pfams)
using both the NCBI Conserved Domain Database
(CDD) and Sanger Institute Protein Family Database
(http://pfam.sanger.ac.uk/) [58]. Conserved AKAP7
Pfams were identified as the AKAP7 Nuclear
Localization Signal (AKAP7 NLS; Pfam 10469) and the
AKAP7 RI/RII binding domain (pfam 10470). Human,
rat and mouse AKAP7 Nucleotide and protein
sequences obtained from NCBI (http://www.ncbi.nlm.
nih.gov) and ENSEMBL were used in BLASTP,
TBLASTN and EST search algorithms to identify
AKAP7 transcripts, proteins and genes in multiple spe-
cies (listed below). Search results were verified to con-
tain both AKAP7 Pfams (AKAP7 NLS and AKAP7 RI/
RII). Sequences obtained from these searches that con-
tained only the AKAP7 NLS Pfam were classified as
“AKAP7-like proteins. Multiple species spanning the
vertebrate and invertebrate lineages were used for this
study, specifically: primates-Homo sapiens (H. sap), Pan
trogylodytes (P.tro), Macaque mulatta (M. mul) Calli-
thrix jacchus (C. jac), rodents-Mus musculus (M. mus),
Rattus norvegicus (Rnor), Oryctolagus cuniculus (O. cun);
laurasiatheria- Canis familiaris (C. fam), Equus caballus
(E. cab), Bos Taurus (B. tau), Sus scrofa (S. scr),
metatheria- Monodelphis domestica (M. dom), reptiles-
Anolis carolinensis (A. car), amphibians- Xenopus tropi-
calis (X. tro), teleosts- Danio rerio (D. rer), Takifugu
rubripes (T. rub), Oryzias latipes (O. lat), Gasterosteus
aculeatus (G. acu); vertebrates- Petromyzon marinus
(Pmar); chordates- Ciona intestinalis (C. int).
Development of PKA-R and AKAP7 interaction
To determine the relationship between AKAP7 RI/RII
binding domain and PKA-R gene evolution, we con-
structed a PKA-R phylogenetic tree from the PKA-R
cAMP binding domains, and identified AKAP7 RI/RII
binding domain presence/absence for each species used
in the PKA-R phylogenetic tree. PKA-R translated amino
acid sequences were aligned using the Clustal function
of Mega v5 [59]. PKA-R subunit protein relationships
were determined using the algorithm of Mr. Bayes 3.1.2.
Mr. Bayes analysis was run under a fixed rate Dayhoff
model. The tree is a representative of 4 independent
runs, of four million generations each. The tree wasrooted with Drosophila melanogaster. Pictoral represen-
tation of AKAP7 RI/RII presence/absence is shown next
to the PKA-R clades that contain this motif.
EST to Gene alignments
To determine AKAP7 splice variant exon positions and
gene structures, the AKAP7 genes of human, rat, dog,
opossum, zebrafish, lamprey, and ciona were analyzed
using GENESCAN [60] and Promoter 2.0 Prediction
Server [61] FPROM (Softberry, Inc., Mt Kisco, NY) pro-
grams. AKAP7 splice variant exon positions and splice
junctions were verified by using NCBI two-sequence
BLAST (bl2seq) and manually aligning cDNA sequences
to the genomic sequences using Mega v5 [59].
Animals
All experiments involving animal subjects were carried
out with the approval of the University of Illinois-
Chicago (UIC) and Jesse Brown VA Medical Center
(JBVAMC) Institutional Animal Care and Use Commit-
tees (IACUC). Adult male rats and mice were used for
cardiac and renal tissue preparations in DNA sequen-
cing, western blotting and immunofluorescence
applications.
AKAP7 Splice variant detection and sequencing
Human multiple tissue cDNA (MTC panel I, CloneTech,
CA) was used in PCR amplification and sequencing
applications. Rat and mouse total RNA were prepared
using Trizol reagent (Invitrogen). Five micrograms of
total RNA was used in first-strand cDNA synthesis using
SuperScript III Reverse Transcriptase (Invitrogen)
primed with random hexamers. PCR was performed
using KOD Hot Start DNA polymerase (EMD Bios-
ciences). Primers used for the amplification of human,
mouse and rat AKAP7α, β, and δ splice variants are
listed in Table 1. PCR products were extracted from
agarose gels and cloned into the pGEM-T vector system
(Promega) and sequenced using a capillary sequencer
(Applied Biosystems).
Transfections
Mouse AKAP7δ, AKAP7γ and rat AKAP7δ transcripts
were PCR amplified from heart or kidney cDNA tem-
plates and cloned into a pcDNA3.1/V5-His expression
vector (Invitrogen) to produce V5-tagged proteins. For
transient transfection purposes, 2x105 HEK293 cells
(American Tissue Culture Collection) were grown on 6-
well plates for 24 h in Dulbecco's Modified Eagle
Medium, 10 % Fetal Bovine Serum (FBS) (BioWhitaker),
100 U/mL penicillin and 50 μg/mL streptomycin. Cell
transfections were performed by using Lipofectamine
2000 (Invitrogen Life Technologies) according to the
manufacturer’s instructions. Cells were transfected with
Table 1 Primers used in PCR amplifications and Sequencing
Name Sequence 5’ to 3’
Human AKAP7δ For ATGGAGCGCCCCGAAGCGGGAGGAATTAAT
Human pan AKAP7 Rev TCATTTCCTGTTGTTCTCATTGTCATTGCCATTCTGATCA
Human AKAP7α For ATGGGCCAGCTTTGCTGCTTTCCTTTCTCAAG
Human AKAP7β For GAGTTGGAAAGCTCGTCCTCTGCAGTCCTAC
Human AKAP7δ-indel set 1 For ATGGAGCGCCCCGAAGCGG
Human AKAP7δ-indel set 1 Rev TTTCCTCTTCTTTACTTGATCACTCTTGACCCATTCATT
Human AKAP7δ-indel set 2 For TTCATAGAAGAACTCCTCCAGGGAAAACATTTGACTTTG
Human AKAP7δ-indel set 2 Rev GAAGATTCACAGTGATAATAACCATTACTTTGTTTT
Human AKAP7δ-indel set 3 For CCTGGTAGGAGAGAGCAGAAGTTTTAAACCTCATTTGAC
Human AKAP7δ-indel set 3 Rev TCCACCAGCCTCTTACTGAGCCTTACTAGTTC
Mouse AKAP7δ For CACCATGGAGCGCCCCGCCGT
Mouse pan AKAP7 Rev CTTCCGGTTGTTATCACTGCCATCACCATTCCGAT
Mouse AKAP7γ For CACCATGCCGTTTGCTGCTGTAGATATTCAAGATGA
Mouse AKAP7α For ATGGGCCAGCTTTGCTGCTTCCCTTTCG
Mouse AKAP7β For GAGTTGGAAAATCCATCTTCTGCAGACCTACAGAG
Mouse AKAP7γ-short Rev TTAGTGCCCAGGGTGGAGCTTTGGAGCAGT
Rat AKAP7δ For CACCATGGAGCGCCCCGCCGCGGGA
Rat pan AKAP7 Rev CTTCCGGTTGTTATCACTGCCATCGCCATTCC
Rat AKAP7α For ATGGGCCAGCTTTGCTGCTTCCCC
Rat AKAP7β For CAGTTGGAAAGTCCATCTTCTGCAATCCTACAGAGAT
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Transfected and mock-transfected cells were harvested
48 hours after transfection and washed with PBS fol-
lowed by sonication in deionized urea-thiourea-chaps
buffer (UTC; 8 M urea, 2 M Thiourea, 2 % chaps) with
protease and phosphatases inhibitors (Pierce). Superna-
tants were then used in 2D western applications.
Immunoprecipitations
Immediately following removal, rat and mouse hearts
were fast-frozen in liquid nitrogen and dounce homoge-
nized at 4°C in 50 mmol/L of Tris–HCl (pH 7.4),
150 mmol/L of NaCl, 1 mmol/L of EDTA, 0.25 % so-
dium deoxycholate, 1 % triton X-100 and 1X HALT pro-
tease and phosphatases inhibitor cocktails (Pierce). The
homogenate was centrifuged at 10,000X RCF for 15
minutes at 4°C, the supernatant was collected and pro-
tein concentrations were determined using the Dc Pro-
tein Assay (BioRad). Five hundred micrograms of the
heart lysates were incubated in 500 μl lysis buffer con-
taining 1 μg of rabbit polyclonal AKAP7 antibody with
slow rotation on a rocker overnight at 4°C. Negative
control immunoprecipitations were carried out using
rabbit IgG (pre-immune serum) instead of the AKAP7
antibody. Lysate-immunoglobulin samples were then
incubated with 50 μl of protein A/G agarose beads
(EMD) for 2 hours under constant rotation. The sampleswere then centrifuged, supernatants were removed and
agarose bead pellets were successively washed in PBS
containing 1.00 %, 0.5 %, and 0.05 % Tween-20. The
beads were resuspended in deionized UTC buffer with
protease and phosphatases inhibitors, mixed and incu-
bated at room temperature for 10 minutes. Following
centrifugation, the supernatants were used in 2D West-
ern applications.Two-dimensional western analysis
Samples from transfections and heart lysate immunopre-
cipitations were centrifuged for 10 minutes at 10,000
RCF and the protein content of the supernatants was
estimated using the RC/DC protein assay (BioRad). Fifty
micrograms of total protein was isoelectrically focused
(IEF) using 7 cm isolated pH gradient (IPG, pH 3–10
non-linear gradient) strips on an IEF cell (BioRad).
Second-dimensional separations were performed on 4-
15 % gradient tris-glycine SDS-PAGE gels. Proteins were
transferred to PVDF membranes for western analysis.
To detect recombinant AKAP7 proteins from transfec-
tions, membranes were probed using an anti-V5 HRP-
conjugated antibody (Invitrogen) at a 1:5000 dilution.
Proteins from AKAP7 immunoprecipitations were
detected with a protein-A HRP conjugate. In negative
control immunoprecipitations, rabbit IgG was used in
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taken on a Kodak image station 4000R pro.
Immunofluorescence microscopy
Affinity-purified rabbit polyclonal pan-AKAP7 antisera
was produced by Genscript corp. (Piscataway, NJ) for
use in immunoprecipitations and immunofluorescence
applications in rat and mouse hearts. The epitope used
for AKAP7 antisera production was “LVRLSKRLVE-
NAVC” which is common to rodent and human AKAP7
splice variants. Following removal, rat and mouse hearts
were fixed overnight with 10% formalin in 0.1 M phos-
phate buffer (pH 7.2). Tissues were dehydrated in graded
ethanol solutions and embedded in paraffin. Nonspecific
staining was blocked by incubation with 1.5 % normal
goat serum in PBS for 1 hr at room temperature in a hu-
midified atmosphere. The sections were incubated with
the anti-AKAP7 antibody or normal rabbit serum (for
negative control) overnight at 4 C. After three washes of
10 min each in PBS-T, the sections were incubated with
Alexa fluor 488-conjugated anti-rabbit secondary anti-
body (Invitrogen) for 2 hours at room temperature
and washed three times. Nuclei were counterstained
with Dapi.
Additional files
Additional file 1: Figure S1. AKAP7 Splice Variant Evolution. EST
classification and EST to gene matching shows the differential
incorporation of AKAP7 splice variants throughout evolution. A
cladogram was constructed using the NCBI taxonomy common tree tool
and matches known species phylogenetic relationships. The accession
numbers from NCBI or Ensemble databases and corresponding exon-
intron structures in each species (determined by EST to gene matching)
for the AKAP7 splice variants is shown in each column. A splice variant is
indicated as “not present” if the exon(s) for that splice variant are absent
from the AKAP7 gene. A splice variant is indicated as “not detected” if
the necessary exons are identified in the AKAP7 gene but no EST was
identified. Splice variants with a non-orthologous AKAP7γ exon-1 are
listed as AKAP7γ-like.
Additional file 2: Figure S2. Nucleotide and Amino acid alignments
of human, mouse and rat AKAP7δ. (A) Human and mouse AKAP7δ
splice variants were sequenced and aligned to the previously reported
rat AKAP7δ nucleotide sequence. Predicted mutations in the AKAP7γ
initiation codon are confirmed, and indicated by an (*). There is 78-89 %
sequence identity between rat, mouse, and human AKAP7δ nucleotide
sequence. The least similar region is found between nucleotides 180 and
200, (B) translated amino acid sequences were aligned using ClustalX2.
Rat and mouse AKAP7δ contain an “RGD” domain between amino acids
70 and 75, this domain is absent from the human sequence.
Additional file 3: Figure S3. Splice variants of Rat AKAP7δ. (A) PCR
amplification of AKAP7δ from rat heart cDNA yielded two smaller splice
variants in addition to the native form. (B) Rat AKAP7δ variant-1 has an
exon-7 deletion, whereas AKAP7δ variant-2 consists of exons 1, 2 and 8,
while exons 3–7 are deleted. Rat AKAP7δ variant-1 contains the AKAP7
NLS (dotted underline) but not the AKAP7 RI/RII binding domain. Rat
AKAP7δ variant-2 lacks the AKAP7 NLS but contains the AKAP7 RI/RII
binding domain (box).
Additional file 4: Figure S4. Mouse AKAP7γ splice variant. A short
splice variant consisting of AKAP7γ exons 1 and 2, and a unique 3’ exon
was identified in mouse ESTs. (A) This truncated splice variant containsthe AKAP7 NLS (dotted box), but lacks the AKAP7 RI/RII binding domain.
A model was constructed (B) to show the relative positions of
constituent exons. (C) The mouse AKAP7γ short variant is not widely
expressed, and is detected only in the spleen.
Additional file 5: Figure S5. Nucleotide and amino acid alignments
of AKAP7 short form splice variants. (A) The amino terminus of
AKAP7α and AKAP7β was aligned using clustalX2. Amino acid sequences
are highly conserved from zebrafish to humans. Residues that have been
previously identified as lipid-modified [1] are indicated by ({) and
hydrophobic residues are indicated with down-arrows (#). (B) The
AKAP7β-specific region is identified in species from pig to humans, with
several highly conserved residues which are indicated with (*).
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